These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15497717)

  • 1. [Pharmacodynamics and pharmacokinetics of vardenafil in patients with erectile dysfunction].
    Jin J; Guo Y
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):711-6. PubMed ID: 15497717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.
    Bischoff E
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S34-7. PubMed ID: 15224134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
    Traish A; Kim N
    J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.
    Gupta M; Kovar A; Meibohm B
    J Clin Pharmacol; 2005 Sep; 45(9):987-1003. PubMed ID: 16100293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
    Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
    BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of vardenafil for men with erectile dysfunction].
    Zhu J; Jiang H
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):704-10. PubMed ID: 15497716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vardenafil treatment for erectile dysfunction.
    Crowe SM; Streetman DS
    Ann Pharmacother; 2004 Jan; 38(1):77-85. PubMed ID: 14742800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of phosphodiesterase-5 inhibitors.
    Corbin JD; Francis SH
    Int J Clin Pract; 2002; 56(6):453-9. PubMed ID: 12166544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of food and alcohol on the pharmacokinetics of vardenafil].
    He ZJ
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):477-9. PubMed ID: 15999499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5).
    Corbin JD; Beasley A; Blount MA; Francis SH
    Neurochem Int; 2004 Nov; 45(6):859-63. PubMed ID: 15312980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study.
    Klotz T; Sachse R; Heidrich A; Jockenhövel F; Rohde G; Wensing G; Horstmann R; Engelmann R
    World J Urol; 2001 Feb; 19(1):32-9. PubMed ID: 11289568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily vardenafil for 6 months has no detrimental effects on semen characteristics or reproductive hormones in men with normal baseline levels.
    Jarvi K; Dula E; Drehobl M; Pryor J; Shapiro J; Seger M
    J Urol; 2008 Mar; 179(3):1060-5. PubMed ID: 18206950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection.
    Bischoff E; Schneider K
    Int J Impot Res; 2001 Aug; 13(4):230-5. PubMed ID: 11494080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors.
    Sussman DO
    J Am Osteopath Assoc; 2004 Mar; 104(3 Suppl 4):S11-5. PubMed ID: 15083994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular studies of vardenafil].
    Jiang H
    Zhonghua Nan Ke Xue; 2005 May; 11(5):396-9. PubMed ID: 15934468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in researches on the onset and duration of the action of sildenafil].
    Wang HP; Pu XY
    Zhonghua Nan Ke Xue; 2005 May; 11(5):392-5. PubMed ID: 15934467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of erectile dysfunction.
    Dinsmore W
    Int J STD AIDS; 2004 Apr; 15(4):215-21. PubMed ID: 15075013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.